, Chagas disease: "the new HIV/AIDS of the Americas, vol.6, p.1498, 2012.
American trypanosomiasis (Chagas disease), Infect. Dis. Clin. North Am, vol.26, issue.2, pp.275-291, 2012. ,
Autoimmune pathogenesis of Chagas heart disease: looking back, looking ahead, Am. J. Pathol, vol.185, issue.6, pp.1537-1547, 2015. ,
Inhibitory receptors are expressed by Trypanosoma cruzi-specific effector T cells and in hearts of subjects with chronic Chagas disease, PLoS ONE, vol.7, issue.5, p.35966, 2012. ,
Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection, Cochrane Database Syst. Rev, vol.27, issue.5, p.3463, 2014. ,
Course of chronic Trypanosoma cruzi infection after treatment based on parasitological and serological tests: a systematic review of follow-up studies, PLoS ONE, vol.10, issue.10, p.139363, 2015. ,
Randomized trial of benznidazole for chronic Chagas' cardiomyopathy, N. Engl. J. Med, vol.373, issue.14, pp.1295-1306, 2015. ,
Experimental vaccines against Chagas disease: a journey through history, J. Immunol. Res, p.489758, 2015. ,
Prophylactic and therapeutic DNA vaccines against Chagas disease, Parasit. Vectors, vol.8, issue.121, p.121, 2015. ,
A two-component DNA-prime/ protein-boost vaccination strategy for eliciting long-term, protective T cell immunity against Trypanosoma cruzi, PLoS Pathog, vol.11, issue.5, p.1004828, 2015. ,
A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy, PLoS Pathog, vol.11, issue.1, p.1004594, 2015. ,
Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice, Infect. Immun, vol.72, issue.1, pp.46-53, 2004. ,
Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects, Expert Rev. Vaccines, vol.11, issue.9, pp.1043-1055, 2012. ,
Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic Trypanosoma cruzi immunity involving CD8 + CTL and B cell-mediated crosspriming, J. Immunol, vol.179, issue.10, pp.6889-6900, 2007. ,
Intranasal vaccinations with the trans-sialidase Antigen plus CpG Adjuvant induce mucosalimmunity protective against conjunctival Trypanosoma cruzi challenges, Infect. Immun, vol.78, issue.3, pp.1333-1338, 2010. ,
Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease, Vaccine, vol.33, issue.10, pp.1274-1283, 2015. ,
Targeting CCR4 as an emerging strategy for cancer therapy and vaccines, Trends Pharmacol. Sci, vol.35, issue.4, pp.163-165, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455519
Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model, Proc. Natl Acad. Sci. USA, vol.111, issue.2, pp.787-792, 2014. ,
Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection, Hum. Vaccin. Immunother, 2015. ,
A brief history of the global effort to develop a preventive HIV vaccine, Vaccine, vol.31, issue.35, pp.3502-3518, 2013. ,